Tyne Shek

The pharma shared the development in a notice to the Pakistan Stock Exchange (PSX) on Friday.

“We are pleased to inform you that after securing requisite approvals, AGP Limited, through a SPV- OBS Pakistan (Private) Limited, has successfully acquired a portfolio of certain pharmaceutical brands from Viatris Inc. which are commercialized in Pakistan primarily under the brands previously owned by Pfizer Inc.,” read the notice.

Viatris was formed in 2020 when pharma company Mylan merged with Upjohn, Pfizer’s off-patent medicine division.

AGP said that the portfolio it has acquired include a broad range of anti-depressants, anti- hypertensive and opthalmogoly products.

It said all the brands are well established with high brand equity and strong customer loyalty, including Zoloft, Cardura, Lyrica and Lipitor. The largest brand in the portfolio is Norvasc, which it said has recorded a turnover of Rs1.3 billion during the last 12 months as per a report issued by IQVIA Solutions Pakistan.

Pakistani pharma aims to acquire Sandoz owned brands to enhance share

The acquisition is expected to result in a significant increase in the consolidated revenues of AGP, which is expected to cross Rs20 billion over the next 12 months.

Cairns Chinese Friendship Garden

Address: Greenslopes St, Edge Hill QLD 4870, Australia

The main ingredient raw fatback can only be obtained by butchering animals. Fat can then be acquired after boiling the said ingredient.